Key result
CRT case report details use in Ebstein's anomaly and LVNC without reporting clinical outcomes.
Why the study?
Ebstein's anomaly can present with arrhythmias, conduction system disease, and biventricular failure that are difficult to manage due to anatomical considerations.
Case Report (n=1)
Describes the use of cardiac resynchronization therapy in a patient with Ebstein's anomaly and left ventricular noncompaction.
Evidence too limited to guide CRT use in Ebstein's anomaly with LV noncompaction; leaves open need for systematic evaluation.
Ebstein’s anomaly (EA) is a rare congenital heart disease accounting for less than 1% of all cardiac congenital anomalies. Numerous structural abnormalities may occur in EA; however, it is chiefly characterized by apical displacement of the septal and posterior leaflets of the tricuspid valve (TV). This leads to “atrialization” of the right ventricle and dilatation of the right atrium. Left ventricular (LV) noncompaction and ventricular pre-excitation are also recognized associations.1 EA can therefore manifest with challenging arrhythmias, conduction system disease, and biventricular failure, which, owing to anatomical considerations, can be difficult to manage.
No takes yet. Share an insight, caveat, or question.
Dwivedi et al. (2022) conducted a case report in Ebstein's anomaly and left ventricular noncompaction (n=1). Cardiac resynchronization therapy was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: